Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Correvio Pharma Corp. CORV

Healthcare Drug Manufacturers - Major
Correvio Pharma Corp is specialty pharmaceutical company. It offers patients and healthcare providers therapeutic solutions for acute medical conditions to improve health and quality of life. Its products are Aggrastat, Esmocard, Brinavess, Xydalba, Zevtera/Mabelio, and others. It offers solutions on Acute Bacterial Skin and Skin Structure Infections, Acute Coronary Syndromes, Atrial... see more

Recent & Breaking News (NDAQ:CORV)

Correvio Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Correvio Pharma Corp. To Contact The Firm

Newsfile January 16, 2020

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baozun, Adamas Pharmaceuticals, Cintas, and Correvio Pharma and Encourages Investors to Contact the Firm

GlobeNewswire January 15, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline - CORV

ACCESSWIRE IA January 14, 2020

Correvio Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Correvio Pharma Corp. To Contact The Firm

Newsfile January 14, 2020

CORV DEADLINE: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Correvio Pharma Corp. - CORV

GlobeNewswire January 13, 2020

INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Correvio Pharma Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA January 13, 2020

DEADLINE ALERT for ACB, PRU, FCAU, CORV: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire January 10, 2020

INVESTOR ALERT: CTAS and CORV: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders With Losses Exceeding $100K of Class Action Deadlines

ACCESSWIRE IA January 10, 2020

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Adamas Pharmaceuticals, Cintas, Correvio Pharma, and Exelon and Encourages Investors to Contact the Firm

GlobeNewswire January 9, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline - CORV

GlobeNewswire January 9, 2020

LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm

PR Newswire January 9, 2020

ROSEN, A LEADING LAW FIRM, Reminds Correvio Pharma Corp. Investors of Important Deadline in Securities Class Action - CORV

GlobeNewswire January 8, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline - CORV

ACCESSWIRE IA January 6, 2020

SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Correvio Pharma Corp.- CORV

GlobeNewswire January 6, 2020

SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline - CORV

GlobeNewswire January 3, 2020

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Correvio Pharma Corporation

Business Wire January 3, 2020

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Correvio Pharma Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA January 2, 2020

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cintas, Correvio Pharma, Exelon, and Green Dot, and Encourages Investors to Contact the Firm

GlobeNewswire January 2, 2020

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Correvio Pharma Corporation

Business Wire January 2, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline - CORV

ACCESSWIRE IA December 31, 2019